Chronic Kidney Disease, Stage 3 (Moderate) Clinical Trial
Official title:
Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4
Hyperphosphatemia is a severe complication to chronic kidney disease (CKD) and is associated with increased risk of vascular calcification, cardiovascular morbidity and mortality. Early dietary intervention and improvement in dietary therapy might optimally reduce cardiovascular complications. For this purpose the investigators investigated patients with CKD stage 3-4, the participants dietary habits, developed a New Nordic Renal Diet and investigated the short term effect on phosphorus homeostasis.
Development of the New Nordic Renal Diet The NND was not suitable for CKD patients in its
present form because of too high phosphorus content. By going through the diet composition in
details and reducing some of the phosphorus rich food items such as nuts, dairy products, rye
bread and fish and reducing the daily intake of meat to a total of 120 mg/day we designed the
NNRD with a total of 850 mg phosphorus per day and 0.8 g protein per kg per day. Two main
principles were important; affordable and palatable.
Phosphorus content of the meals The nutrient content of the meals were based on information
from the Danish food composition data bank; Dankost 3000® (version 7.01, 2009, Dankost,
Copenhagen, Denmark). The diets during the intervention were designed to be iso-caloric. The
phosphorus content in the samples was determined by inductively coupled plasma mass
spectrometry (ICPMS) at the National Food Institute at the Technical University of Denmark.
Briefly, the samples were lyophilized and homogenized to a fine powder. Subsamples (0.3 g)
were digested with concentrated nitric acid in a microwave oven (Multiwave 3000, Anton Paar,
Graz, Austria). The quantification of phosphorus (31P) was done with external calibration
using 45Sc as internal standard. The ICPMS (Thermo iCAPq, Bremen, Germany) was run in KED
mode using helium as cell gas. For quality assurance of the results, the certified reference
material BCR63R (Skim milk powder) was analyzed and the obtained results (10.9+/-0.3 mg/g)
were in good agreement with the certified target value (11.1+/-0.13 mg/g).
Study Nineteen patients were recruited from the outpatient clinic at the Department of
Nephrology, Copenhagen University, Rigshospitalet and 1 patient from Department of
Nephrology, Copenhagen University, Herlev Hospital.
This was a randomized controlled crossover study of two diets in patients with CKD stage 3-4
(figure 1). Baseline data (day 0) was obtained including 24-h urine collection, fasting blood
samples and dietary record. During the intervention the participants received our phosphorus
reduced version of the NND termed the NNRD for 1 week, fasting blood samples was achieved on
day 1 and 4 together with 24-hour urine collection. During the control period the
participants kept to their habitual diet from day 1 - 6 (on day 1 and day 4, they kept a
dietary record and collected 24-h urine) and on day 7 they received a control diet with a
phosphorus content in accordance with an average Danish diet (1500 mg). On day 7, in both the
two intervention periods, the patients were admitted to the Department of Nephrology,
University Hospital of Copenhagen, Rigshospitalet to follow the circadian rhythm of plasma
phosphate, plasma intact FGF23, plasma calcium and plasma PTH. Fasting blood sample and 24-h
urine collection was obtained, and blood was additionally drawn 30 min after each of the
three meals.
During the NNRD intervention there were two daily meals, given with a two-day rotation. Diet
planning and analysis was initially done using the Food Composition Data bank (version 7.01,
2009, Copenhagen, Denmark). The actual measured phosphorus content was equal to the
calculated value from the Food Composition Data bank and the diets were kept unchanged.
Self-reporting questionnaire The dietary compliance, satisfaction and satiation were judged
by written self-reported questionnaire during the NNRD (supplemental material). Dietary
satisfaction was judged by a five-level Likert scale with following response options: very
good, good, okay, not good and bad. A similar method was used for the dietary compliance with
the following response options: 100%, 80%, 60%, 40% and 20%. The satiation was judged by yes
or no.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04960514 -
Prospective Decision Impact Trial of KidneyIntelX
|
||
Active, not recruiting |
NCT04087798 -
Controlling Hypertension Through Education and Coaching in Kidney Disease
|
N/A | |
Completed |
NCT03795389 -
Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
|
Phase 1 | |
Not yet recruiting |
NCT04827290 -
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
|
N/A |